• Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis 

      Hindy, George; Tyrrell, Daniel J.; Vasbinder, Alexi; Wei, Changli; Presswalla, Feriel; ... more authors ( American Society for Clinical Investigation , 2022 , Article)
      People with kidney disease are disproportionately affected by atherosclerosis for unclear reasons. Soluble urokinase plasminogen activator receptor (suPAR) is an immune-derived mediator of kidney disease, levels of which ...